18.11.2025
Pharmaceutical Entrepreneurs vs. Contract Manufacturers: Who (real-ly) bears the risk of liability under Section 84 of the German Medicines Act (AMG)?

10.11.2025
Update on First Brands insolvency: UBS funds affected & parallels with Greensill

04.11.2025
Dawn raids at Red Bull: General Court clarifies preconditions for adopting an inspection decision and confirms the Commission’s wide discretion in conducting its antitrust investigations

17.10.2025
Termination in the event of insolvency: Why standard insolvency-dependent termination clauses often fail and how they can be made effective

09.10.2025
UBS funds and the insolvency of First Brands: A new Greensill debacle for investors?

08.10.2025
EU Commission investigates SAP regarding licensing of ERP software – What does this mean for SAP customers?

22.09.2025
News from export control: Russia/Belarus embargo – 18th EU sanctions package of July 18, 2025

19.09.2025
Tips on contract negotiation for non-lawyers (Part 2)

28.07.2025
“Silence means defeat” – On the secondary burden of demonstration in contestation proceedings Judgment of the Federal Court of Justice of 6 March 2025 – IX ZR 209/23